Latest Period
Q4 2025
Security Snapshot
RenovoRx, Inc. - Common Stock (RNXT) Institutional Ownership
CUSIP: 75989R107
13F Institutional Holders and Ownership History from Q3 2021 to Q1 2026
Institutions Reporting
33
Shares (Excl. Options)
6,575,061
Price
$0.84
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common Stock
- Symbol
- RNXT on Nasdaq
- Shares outstanding
- 45,209,112
- Price per share
- $1.01
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 6,575,061
- Total reported value
- $6,828,142
- % of total 13F portfolios
- 0%
- Share change
- -553,770
- Value change
- -$803,083
- Number of holders
- 33
- Price from insider filings
- $1.01
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- RNXT - RenovoRx, Inc. - Common Stock is tracked under CUSIP 75989R107.
- 33 institutions reported positions in Q4 2025.
- 2 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 33 to 4 between Q4 2025 and Q1 2026.
- Reported value moved from $6,828,142 to $138,112.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 33 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 75989R107?
CUSIP 75989R107 identifies RNXT - RenovoRx, Inc. - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 75989R107:
Significant Owners of RenovoRx, Inc. - Common Stock (RNXT) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| HIRSCHMAN ORIN | 9.8% | +39% | $4,474,798 | +$1,833,453 | 4,430,493 | +69% | AIGH Capital Management LLC | 31 Mar 2026 |
| AWM Investment Company, Inc. | 2.4% | -54% | $1,097,013 | -$1,278,172 | 863,790 | -54% | AWM Investment Company, Inc. | 30 Sep 2025 |
As of 31 Dec 2025, 33 institutional investors reported holding 6,575,061 shares of RenovoRx, Inc. - Common Stock (RNXT). This represents 15% of the company’s total 45,209,112 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of RenovoRx, Inc. - Common Stock (RNXT) together control 14% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 6.3% | 2,833,894 | +8.4% | 1.1% | $3,671,068 |
| VANGUARD GROUP INC | 3.6% | 1,605,079 | 0% | 0% | $1,348,267 |
| Bleichroeder LP | 1.3% | 600,000 | +11% | 0.09% | $504,060 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.82% | 371,393 | -0.02% | 0% | $312,024 |
| Wealthspire Advisors, LLC | 0.56% | 252,525 | 0% | $212,147 | |
| RENAISSANCE TECHNOLOGIES LLC | 0.26% | 117,457 | -63% | 0% | $98,676 |
| NIXON PEABODY TRUST CO | 0.21% | 97,165 | 0% | 0.01% | $81,628 |
| Chicago Partners Investment Group LLC | 0.2% | 92,356 | 0% | 0% | $91,968 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.2% | 90,009 | 0% | $75,617 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 0.17% | 74,616 | +0.03% | 0% | $62,685 |
| Caprock Group, LLC | 0.14% | 63,940 | 0% | $53,716 | |
| CITADEL ADVISORS LLC | 0.12% | 53,408 | -56% | 0% | $44,868 |
| XTX Topco Ltd | 0.11% | 50,140 | +59% | 0% | $42,123 |
| NORTHERN TRUST CORP | 0.09% | 42,161 | 0% | 0% | $35,419 |
| Kestra Advisory Services, LLC | 0.08% | 35,520 | 0% | 0% | $29,840 |
| STATE STREET CORP | 0.06% | 26,152 | 0% | 0% | $21,970 |
| Cypress Point Wealth Management, LLC | 0.04% | 20,000 | 0% | $16,802 | |
| HighTower Advisors, LLC | 0.04% | 20,000 | -50% | 0% | $16,802 |
| TWO SIGMA SECURITIES, LLC | 0.04% | 19,649 | 0% | $16,507 | |
| JANE STREET GROUP, LLC | 0.03% | 13,905 | +1.1% | 0% | $11,682 |
| Ground Swell Capital, LLC | 0.03% | 13,611 | 0.02% | $11,435 | |
| Affinity Capital Advisors, LLC | 0.03% | 13,279 | 0% | 0% | $11,156 |
| CAPTRUST FINANCIAL ADVISORS | 0.03% | 12,307 | 0% | 0% | $10,339 |
| Cetera Investment Advisers | 0.02% | 11,000 | 0% | $9,241 | |
| Focus Partners Wealth | 0.02% | 11,000 | 0% | 0% | $9,241 |
Institutional Holders of RenovoRx, Inc. - Common Stock (RNXT) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 136,744 | $138,112 | -$16,473 | $1.01 | 4 |
| 2025 Q4 | 6,575,061 | $6,828,142 | -$803,083 | $0.84 | 33 |
| 2025 Q3 | 7,128,831 | $9,039,937 | -$2,116,515 | $1.27 | 31 |
| 2025 Q2 | 8,793,596 | $11,583,502 | -$1,364,639 | $1.32 | 25 |
| 2025 Q1 | 10,076,151 | $9,978,521 | +$8,940,185 | $0.99 | 26 |
| 2024 Q4 | 1,013,351 | $1,308,316 | -$906,715 | $1.29 | 18 |
| 2024 Q3 | 1,890,069 | $2,003,493 | +$1,061,320 | $1.06 | 13 |
| 2024 Q2 | 895,016 | $1,011,121 | +$638,727 | $1.13 | 16 |
| 2024 Q1 | 329,531 | $441,598 | -$15,365 | $1.34 | 9 |
| 2023 Q4 | 331,078 | $758,056 | +$55,636 | $2.29 | 11 |
| 2023 Q3 | 363,630 | $473,454 | +$152,282 | $1.33 | 14 |
| 2023 Q2 | 244,336 | $552,200 | -$3,412,215 | $2.26 | 9 |
| 2023 Q1 | 1,211,907 | $4,224,019 | +$3,564,830 | $3.48 | 11 |
| 2022 Q4 | 1,169,112 | $2,747,057 | -$130,733 | $2.35 | 11 |
| 2022 Q3 | 1,229,727 | $2,485,000 | +$85,856 | $2.02 | 11 |
| 2022 Q2 | 1,188,008 | $2,352,000 | +$1,994,918 | $1.98 | 9 |
| 2022 Q1 | 164,728 | $482,000 | +$5,393 | $2.92 | 10 |
| 2021 Q4 | 104,357 | $506,000 | -$319,219 | $4.86 | 7 |
| 2021 Q3 | 169,048 | $1,023,000 | +$1,023,000 | $6.05 | 7 |